Search results for "BODIES"

showing 10 items of 2217 documents

Randomized Study of Early versus Late Immunization with Pneumococcal Conjugate Vaccine after Allogeneic Stem Cell Transplantation

2009

BACKGROUND: Invasive pneumococcal disease is a life-threatening complication after allogeneic stem cell transplantation, and at least 20% of cases occur within 1 year after transplantation. The 23-valent pneumococcal polysaccharide vaccine (PPV23) has limited efficacy, especially during the first year after transplantation. The immune response to the conjugated vaccines is expected to be better than that to the polysaccharide vaccine, but the optimal timing of vaccination is not defined. Our objective was to show that a 7-valent pneumococcal conjugate vaccine (PCV7; Prevnar) was not inferior when first given 3 months after transplantation, compared with when first given 9 months after trans…

AdultMaleMicrobiology (medical)Pediatricsmedicine.medical_specialtyHeptavalent Pneumococcal Conjugate VaccineTime FactorsAdolescentmedicine.medical_treatmentImmunization SecondaryHematopoietic stem cell transplantationPneumococcal conjugate vaccinePneumococcal VaccinesYoung AdultHeptavalent Pneumococcal Conjugate VaccineHumansMedicineChildImmunization Schedulebusiness.industryPneumococcal 7-Valent Conjugate VaccineMiddle AgedAntibodies BacterialPneumococcal polysaccharide vaccineEuropeVaccinationTransplantationInfectious DiseasesImmunizationImmunologyFemalebusinessImmunosuppressive AgentsStem Cell Transplantationmedicine.drugClinical Infectious Diseases
researchProduct

The Acute Phase Response in Sicilian Patients with Boutonneuse Fever Admitted to Hospitals in Palermo, 1992–1997

2001

Abstract Objectives : To study the modifications of some components of the acute phase response (APR) in Sicilian patients with boutonneuse fever (BF) caused by Rickettsia conorii . Methods : Sera from 500 Sicilian patients with confirmed BF were studied at the time of diagnosis and every week after treatment, and after recovery for the presence of various inflammatory mediators. Tumour necrosis factor α (TNFα), interleukin(IL)-6, IL-1α, IL-8, soluble TNF receptors (sTNF-R) and sIL-6R were assayed by commercially ELISA kits. C3, C4, factor B, C-reactive protein (CRP), fibrinogen, ceruloplasmin (Cp) and α 1 -antitrypsin (AAT) were assayed by a rate nephelometry. Results : Interferon gamma (I…

AdultMaleMicrobiology (medical)Time Factorsmedicine.medical_treatmentBoutonneuse FeverFibrinogenmedicineHumansInterferon gammaAcute-Phase ReactionAgedbiologybusiness.industryAcute-phase proteinInterleukinMiddle Agedmedicine.diseasebiology.organism_classificationAntibodies BacterialBoutonneuse feverRickettsia conoriiInfectious DiseasesCytokineItalyImmunologyCytokinesFemaleTumor necrosis factor alphaRickettsia conoriibusinessAcute-Phase Proteinsmedicine.drugJournal of Infection
researchProduct

LIODetect®TB-ST: Evaluation of novel blood test for a rapid diagnosis of active pulmonary and extra-pulmonary tuberculosis in IGRA confirmed patients

2021

Abstract Because of the current limits of immunological tests in the diagnosis of tuberculosis there is a need to identify new and rapid tests that can be carried out on a large scale in endemic countries and useful in the identification of infected subjects, but also able to discriminate those with latent infection from subjects with active. We have taken into consideration and analysed the LIODetect®TB-ST Tuberculosis Rapid Test, a membrane test for the qualitative detection of specific IgG, IgA, and IgM antibodies against Mycobacterium tuberculosis, performed on serum, plasma, or whole blood.85 samples positive to QuantiFERON TB-GOLD PLUS test were processed using this test and the resul…

AdultMaleMicrobiology (medical)TuberculosisIgm antibodyImmunologyDiseaseSensitivity and SpecificityMicrobiologyQuantiferon TB GoldQuantiFERONMycobacterium tuberculosisExtra pulmonary tuberculosisPLUSHumansTuberculosisMedicineBlood testTuberculosis PulmonaryIFN-γHematologic Testsbiologymedicine.diagnostic_testbusiness.industrySpecific iggMycobacterium tuberculosisMiddle Agedbiology.organism_classificationmedicine.diseaseAntibodies BacterialInfectious DiseasesImmunologyFemalebusinessLIODetect®TB-STInterferon-gamma Release Tests
researchProduct

Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus

2010

BACKGROUND: This article describes multiple transmissions of rabies via transplanted solid organ from a single infected donor. The empirical Milwaukee treatment regimen was used in the recipients. METHODS: Symptomatic patients were treated by deep sedation (ketamine, midazolam, and phenobarbital), ribavirin, interferon, and active and passive vaccination. Viral loads and antibodies were continuously monitored. RESULTS: Recipients of both cornea and liver transplants developed no symptoms. The recipient of the liver transplant had been vaccinated approximately 20 years before transplantation. Two recipients of kidney and lung transplants developed rabies and died within days of symptomatic d…

AdultMaleMicrobiology (medical)medicine.medical_specialtyRabiesmedicine.medical_treatmentMedizinLiver transplantationAntibodies Viralmedicine.disease_causeAntiviral AgentsOrgan transplantationmedicineHumansHypnotics and SedativesMononegaviralesLyssavirusAgedbiologybusiness.industryRabies virusOrgan TransplantationMiddle AgedViral Loadmedicine.diseasebiology.organism_classificationSurgeryTransplantationTreatment OutcomeInfectious DiseasesRabies VaccinesRabies virusFemaleRabiesbusinessViral load
researchProduct

Combined kinetic analysis of SARS-CoV-2 RNAemia, N-antigenemia and virus-specific antibodies in critically ill adult COVID-19 patients

2022

Combined kinetic analysis of plasma SARS-CoV-2 RNAemia, Nucleocapsid (N)-antigenemia and virus-specific antibodies may help ascertain the role of antibodies in preventing virus dissemination in COVID-19 patients. We performed this analysis in a cohort of 71 consecutive critically ill COVID-19 patients (49 male; median age, 65 years) using RT-PCR assay, lateral flow immunochromatography method and receptor binding domain (RBD) and N-based immunoassays. A total of 338 plasma specimens collected at a median of 12 days after symptoms onset were available for analyses. SARS-CoV-2 RNAemia and N-antigenemia were detected in 37 and 43 specimens from 26 (36.5%) and 30 (42.2%) patients, respectively.…

AdultMaleMultidisciplinaryPatientsSARS-CoV-2virusesCritical IllnessMicrobiologiaCOVID-19Antibodies ViralAntibodiesVirusKineticsRNAemiaResposta immunitàriaHumansRNA ViralAged
researchProduct

Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation

2014

Intrathecal oligoclonal bands of the cerebrospinal fluid are considered the most important immunological biomarkers of multiple sclerosis. They typically consist of clonally expanded IgG antibodies that underwent affinity maturation during sustained stimulation by largely unknown antigens. In addition, ∼40% of patients with multiple sclerosis have oligoclonal bands that consist of expanded IgM antibodies. We investigated the molecular composition of IgM- and IgG-chains from cerebrospinal fluid of 12 patients with multiple sclerosis, seven patients with other neurological diseases, and eight healthy control subjects by high-throughput deep-sequencing and single-cell PCR. Further, we studied …

AdultMaleMultiple SclerosisMolecular Sequence DataSomatic hypermutationAntibodies Monoclonal HumanizedImmunoglobulin GAffinity maturationYoung AdultmedicineHumansAmino Acid SequenceAgedCell ProliferationAged 80 and overInflammationB-LymphocytesBase SequencebiologyNatalizumabMultiple sclerosisGerminal centerCytidine deaminaseMiddle Agedmedicine.diseaseImmunoglobulin MSpinal CordImmunoglobulin class switchingImmunoglobulin MImmunoglobulin GImmunologybiology.proteinFemaleSomatic Hypermutation ImmunoglobulinNeurology (clinical)Single-Cell AnalysisBrain
researchProduct

Reducing Body Myopathy with Cytoplasmic Bodies and Rigid Spine Syndrome: A Mixed Congenital Myopathy

2001

At the age of five years a male child started to develop a progressive rigid spine, torsion scoliosis, and flexion contractures of his elbows, knees, hips, and ankles owing to severe proximal and distal muscle weakness. He had three muscle biopsies from three different muscles at ages 7, 11, and 14 years, respectively. Myopathologically, these muscle tissues contained numerous inclusions which, at the ultrastructural level, turned out to be reducing bodies and cytoplasmic bodies, often in close spatial proximity. Similar histological inclusions, although not further identified by histochemistry and electron microscopy, were seen in his maternal grandmother's biopsied muscle tissue who had d…

AdultMaleMuscle tissuePathologymedicine.medical_specialtyWeaknessScoliosisSpinal Muscular Atrophies of ChildhoodSarcomereMyositis Inclusion BodymedicineHumansGenetic Predisposition to DiseaseMuscle SkeletalMyopathyMyositisAgedInclusion Bodiesbusiness.industrySyndromeGeneral MedicineAnatomymedicine.diseasePenetrancePedigreemedicine.anatomical_structureChild PreschoolPediatrics Perinatology and Child HealthDisease ProgressionLordosisFemaleDesminNeurology (clinical)medicine.symptombusinessMyopathies Structural CongenitalNeuropediatrics
researchProduct

Characterization of target antigens from anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis type-I.

1997

The occurrence of anti-neutrophil cytoplasmic antibodies (ANCA) has been described in sera of patients with autoimmune hepatitis (AIH). The significance of this finding remains uncertain and the nature of the target antigen(s) has not yet been defined. We studied 32 sera from patients with AIH type-I and prepared extracts of human neutrophils to identify the target antigen(s). A 43 kDa dominant immunoreactive protein was found and identified as the cytoskeletal component actin. Initial studies to define the antigenic determinants identified three different actin domains.

AdultMaleNeutrophilsClinical BiochemistryBlotting WesternMolecular Sequence DataFluorescent Antibody TechniqueAutoimmune hepatitisBiologyBiochemistryAnalytical ChemistryAntibodies Antineutrophil CytoplasmicAutoimmune DiseasesHepatitisEpitopesAntigenimmune system diseasesmedicineTumor Cells CulturedAnimalsHumansAmino Acid SequenceAntigensCytoskeletonAnti-neutrophil cytoplasmic antibodyAgedAged 80 and overMiddle Agedmedicine.diseaseRatsBlotEpitope mappingCytoplasmImmunologybiology.proteinFemaleAntibodyElectrophoresis
researchProduct

Enhancement of endothelial cell E-selectin expression by sera from patients with active Behçet's disease: moderate correlation with anti-endothelial …

1999

We studied the in vitro E-selection expression of endothelial cells treated with sera from patients with Behcet's disease (BD) and factors (anti-endothelial cell antibodies, anti-neutrophil cytoplasmic antibodies, cytokines, and myeloperoxidase (MPO) that may contribute to adhesion molecule expression. A total of 21 patients with BD and 27 healthy controls were studied. In vitro E-selectin endothelial cell expression was investigated by ELISA after HUVEC incubation with sera or purified IgG from patients with BD and controls. Increased E-selectin expression was observed when endothelial cells were incubated with sera from patients with active disease or from patients with circulating anti-e…

AdultMaleNeutrophilsImmunologyCellIn Vitro TechniquesImmunoglobulin GAntibodies Antineutrophil CytoplasmicE-selectinmedicineImmunology and AllergyHumansCells CulturedAgedAutoantibodiesPeroxidasebiologyCell adhesion moleculeBehcet SyndromeAutoantibodyMiddle AgedMolecular biologyEndothelial stem cellmedicine.anatomical_structureMyeloperoxidaseImmunoglobulin GImmunologybiology.proteinCytokinesFemaleEndothelium VascularAntibodyE-SelectinClinical immunology (Orlando, Fla.)
researchProduct

High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell …

2007

On the basis of a preceding phase I study, the current trial explored bendamustine in combination with mitoxantrone and rituximab (BMR) in patients with stage III/IV relapsed or refractory indolent lymphomas and mantle cell lymphoma (MCL) with or without prior rituximab containing chemo-immunotherapy (R-chemo) treatment. Therapy consisted of bendamustine 90 mg/m(2) days 1 + 2, mitoxantrone 10 mg/m(2) day 1, rituximab 375 mg/m(2) day 8. Treatment was repeated on day 29 for a total of four cycles. Between 3 April and 04 July, 57 patients were recruited from 24 participating institutions, 39% of whom had received prior R-chemo therapy. Median age was 66 years (40 - 83). Lymphoma subtypes were …

AdultMaleOncologyBendamustineCancer Researchmedicine.medical_specialtyPathologyPhases of clinical researchLymphoma Mantle-CellAntibodies Monoclonal Murine-DerivedInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineBendamustine HydrochlorideHumansLymphoma FollicularSurvival analysisAgedAged 80 and overSalvage TherapyMitoxantronebusiness.industryLymphoma Non-HodgkinRemission InductionAntibodies MonoclonalHematologyMiddle Agedmedicine.diseaseSurvival AnalysisLymphomaClinical trialTreatment OutcomeOncologyNitrogen Mustard CompoundsMonoclonalFemaleRituximabMitoxantroneRituximabbusinessmedicine.drugLeukemia & Lymphoma
researchProduct